Two different compounds (pictured above) were generated using zinc (left) and manganese (right). Whilst these two compounds ‘look’ very similar the zinc compound demonstrated excellent anti-cancer activity and selectivity towards a range of cancers in the laboratory whereas the manganese compound was comparatively much more toxic, meaning there was more anti-cancer activity at a lower concentration, with similar selectivity compared to current drugs tested.
A team of scientists at the University of Huddersfield has discovered chemical systems that self-assemble into molecular capsules which are highly toxic towards human cancer cells of a range of different tumour types, and which have demonstrated unprecedented cancer selectivity in the laboratory that, in some cases, are many thousands of times more toxic to the cancer cells compared to healthy, normal cells
ONE of the most challenging aspects of cancer treatment is the huge variety of different tumours that can occur with each one potentially requiring a different solution because unfortunately, one drug does NOT fit all. In addition, another major issue of many current drugs is their poor selectivity towards cancers resulting in problems such as normal tissue toxicity, severe side effects and the development of drug resistance.
Now, a team of scientists at the University of Huddersfield is researching how to combat these challenges by using “self-assembled” drugs and although the research is in its very early stages, they’ve already had a breakthrough.
The science behind self-assembly
Self-assembly is the ability to instruct chemical systems with specific information so in the correct environment they will spontaneously generate biologically active compounds. Using this process many different compounds can be rapidly and easily formed with each different self-assembled drug having different chemotherapy properties.
“In the future, it may be possible to target many cancers through this approach with the correct drug ‘self-assembled’ in such a manner to be selective for a specific cancer.”
Professor Craig Rice
In an article published by the journal Nature Communications, the University’s Professor Roger Phillips, Dr Simon Allison and Professor Craig Rice demonstrate chemical systems that self-assemble into molecular capsules which are highly toxic towards human cancer cells of a range of different tumour types.
More importantly, they show unprecedented cancer selectivity in the laboratory that, in some cases, are many thousands of times more toxic to the cancer cells compared to healthy, normal cells.
Cancer therapy without severe side-effects
Eventually, if similar results are obtained in more complex testing systems including in patients, and once considered safe after careful testing, it could offer the possibility of being able to treat cancers without the severe side effects commonly associated with chemotherapy drugs.
“Anti-cancer drug discovery and development can be enormously time consuming and expensive with a particular drug only being effective against a relatively small number of cancers with specific shared properties,” explained Professor Rice who heads the University’s Department of Chemical Sciences and is also the Director of the Structural, Molecular and Dynamic Modelling Centre within the School of Applied Sciences.
“In the future, it may be possible to target many cancers through this approach with the correct drug ‘self-assembled’ in such a manner to be selective for a specific cancer,” said Professor Rice.
Targeting hard-to-treat cancers
The research could also pave the way in targeting hard-to-treat cancers for which commonly used chemotherapy drugs have little or no effect.
The published studies show the new potential drug can be assembled with either zinc, copper, or manganese, with the three metal ions imparting significantly different chemotherapeutic properties via different mechanisms dependent upon which metal ion is used.
“It is this which allows the generation of different chemical systems each of which may have specificity for different cancers,” he said.
Original Article: Cancer therapy breakthrough in vitro using self-assembled drugs
More from: University of Huddersfield
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Self-assembled drugs
- Haryana assembly monsoon session to start from August 8; Opposition to corner government over jobs, law and order situation
Haryana CLP chalked out its strategy for upcoming monsoon session of assembly and decided to corner BJP-JJP government on a range of issues, including “corruption and deteriorating law and order.” ...
- Non-chiral tetrahedrons form chiral superstructures
While doing a routine check on a batch of tiny gold tetrahedrons, Rice chemist Matthew Jones and graduate student Zhihua Cheng found that their microscopic particles had the unanticipated ability to ...
- Nanotechnology Could Have a Crucial Role in Inflammatory Bowel Disease Treatment
A new review focuses on recent advancements in nanotechnology-based treatments for IBD, mainly targeting inflammation and dysregulated gut microbiomes.
- The microparticles behind self-boosting vaccines
A “smart” vaccine may be on the horizon as researchers develop microparticles that can release their contents at different time points, potentially streamlining the vaccination process. Having ...
- Bottom-Up Construction with a 2D Twist Could Yield Novel Materials
Tetrahedron-shaped nanoparticles are known to be highly interesting by themselves under the perfect circumstances. An exceptional breakthrough has been made by the researchers of Rice University.
Go deeper with Google Headlines on:
Self-assembled drugs
Go deeper with Bing News on:
Cancer therapy without severe side-effects
- Scientists at Tel Aviv U. announce 'Breakthrough' in cancer treatment
Researchers have identified a molecule that promises to be more effective than an antibody currently used to treat the disease.
- After four years of treatment for stage 4 cancer I just wanted some encouraging words from my oncologist
My oncologist has one of those little motivational prints hanging on his waiting room wall, with the simple statement: "trust your instincts." One day, bored with the long purgatory of the waiting ...
- ViewRay and Katie Couric Media Partner to Raise Awareness about MRIdian® MRI-Guided Radiation Therapy
ViewRay, Inc, the U.S. maker of the MRIdian System, today announced a partnership with award-winning journalist and cancer advocate Katie Couric's multi-media company, Katie Couric Media ("KCM").
- Hormone Replacement Therapy Not Linked to Breast Cancer Recurrence, Study Finds
Hormone therapy can be an effective treatment for symptoms that affect the genitals and urinary tract in female cancer patients, but researchers still note that certain types of therapies may still ...
- VRd Regimen for Multiple Myeloma: A Guide
The VRd regimen, also written as RVd, is a three-drug therapy doctors often use as the first treatment for myeloma. It tends to be well tolerated and is associated with high remission rates. The three ...